Your browser doesn't support javascript.
loading
Personalized therapy for hepatocellular carcinoma: Where are we now?
Chan, Stephen L; Wong, Alissa M; Lee, Kirsty; Wong, Nathalie; Chan, Allen K C.
Afiliación
  • Chan SL; State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong, Hong Kong; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, and Prince of Wales Hospital, Hong Kong; Institute of Digestive Disease, The Chinese University of Hong Kong, Ho
  • Wong AM; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong. Electronic address: Alissa_48@yahoo.com.
  • Lee K; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, and Prince of Wales Hospital, Hong Kong. Electronic address: kirsty.lee@gmail.com.
  • Wong N; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong. Electronic address: natwong@cuhk.edu.hk.
  • Chan AK; State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong, Hong Kong; Li Ka Shing Institute of Health Sciences, Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong. Electronic address: allen@cuhk.edu.hk.
Cancer Treat Rev ; 45: 77-86, 2016 Apr.
Article en En | MEDLINE | ID: mdl-26995632

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma Hepatocelular / Medicina de Precisión / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma Hepatocelular / Medicina de Precisión / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2016 Tipo del documento: Article